OpenEvidence, ChatGPT for doctors, raises $200M at $6B valuation

OpenEvidencea tool that doctors and nurses have likened to ChatGPT for medicine, plans to announce a $200 million raise at a $6 billion valuation, The New York Times reports.

The new funds come three months after the startup raised $210 million at a valuation of $3.5 billion, evidence of intense investor interest in industry-specific AI applications.

Trained in medical journals from JAMA and the New England Journal of Medicine, the OpenEvidence platform helps users quickly get answers to existing medical knowledge to help treat patients. Certified medical professionals can access the ad-supported OpenEvidence tool for free.

OpenEvidence has grown rapidly since its founding in 2022. The number of clinical consultations per month has nearly doubled to 15 million since July, according to the Times.

The round was led by Google Ventures, with participation from Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, Bond, and Craft.

TechCrunch has reached out to OpenEvidence for comment.